Jubilant Cadista Pharmaceuticals — 23 certified H-1B filings (FY2016–FY2025)
- 1
- Filings · FY2025
- $88k
- Median base · FY2025
- Chemist II
- Top role · 4 all-time
- MD
- Top state · 21 all-time
Jubilant Cadista Pharmaceuticals filed 1 certified H-1B LCAs in FY2025, with a median base salary of $88k and the middle 50% of offers between $88k and $88k. That is 12% above the market median for the same job titles. Across all years it has 23 certified filings since FY2016, most often for Chemist II in Maryland.
How much does Jubilant Cadista Pharmaceuticals pay H-1B workers?
Certified base salary by fiscal year: each box is the p25–p75 range, the heavy line the median, the whiskers reach p10–p90. $88k median in FY2025. Base pay only — hover a year for its figures.
How has Jubilant Cadista Pharmaceuticals's H-1B hiring changed by year?
7 certified filings in FY2016 → 1 in FY2025. The change column is each year against the one before.
| Fiscal year | Filings | vs prior FY | Median base |
|---|---|---|---|
| FY2025 | 1 | 0% | $88k |
| FY2024 | 1 | −50% | $160k |
| FY2023 | 2 | −33% | $154k |
| FY2022 | 3 | +200% | $90k |
| FY2020 | 1 | −75% | $127k |
| FY2019 | 4 | +300% | $81k |
| FY2018 | 1 | −67% | $80k |
| FY2017 | 3 | −57% | $85k |
| FY2016 | 7 | — | $76k |
Which wage levels does Jubilant Cadista Pharmaceuticals file?
DOL prevailing-wage levels I–IV approximate experience tiers (I = entry, IV = fully competent). 81% of Jubilant Cadista Pharmaceuticals's filings sit at Level III–IV. A heavy I–II skew reads as entry-level or contractor-style hiring; a heavy IV skew as senior in-house roles — and higher levels earn more lottery entries.
Share of 16 filings with a wage level · all years
- Level II18.8%3
- Level III50.0%8
- Level IV31.3%5
What jobs does Jubilant Cadista Pharmaceuticals sponsor for H-1B?
The most-filed job titles across all years (DOL titles, employer pay-grade codes stripped), with base-salary percentiles.
| Job title | Filings | Median base |
|---|---|---|
| Chemist II | 4 | $70k |
| Chemist | 3 | $81k |
| Manager Analytical Filing | 2 | $88k |
| Manager, Systems SAP Applications | 2 | $127k |
| Chemist III | 2 | $76k |
| Senior Systems Analyst, SAP Applications | 1 | $117k |
| Sr. Manager, Systems SAP Applications | 1 | $154k |
| Sr. Scientist, Technical Services | 1 | $90k |
| Sr. Validation & Project Engineer | 1 | $85k |
| Supervisor, Quality Assurance | 1 | $80k |
Where does Jubilant Cadista Pharmaceuticals hire H-1B workers?
Worksite states on the certified filings, all years. Deeper pink = more filings; hover a state for its figures.
| State | Filings | Median base |
|---|---|---|
| MD | 21 | $88k |
| PA | 2 | $88k |
What has Jubilant Cadista Pharmaceuticals filed recently?
Every certified LCA on record for Jubilant Cadista Pharmaceuticals: job title, worksite, prevailing-wage level and the offered base salary.
| FY | Job title | Base salary |
|---|---|---|
| 2025 | Batch Release Specialist | $88,000 |
| 2024 | Manager, Technical Services | $160,000 |
| 2023 | Sr. Manager, Systems SAP Applications | $153,793 |
| 2023 | Manager, Systems SAP Applications | $153,793 |
| 2022 | Principal Scientist | $130,000 |
| 2022 | Chemist Quality Control | $88,407 |
| 2022 | Chemist III | $89,656 |
| 2020 | Manager, Systems SAP Applications | $127,091 |
| 2019 | Chemist | $82,254 |
| 2019 | Sr. Scientist, Technical Services | $90,235 |
| 2019 | Chemist | $78,281 |
| 2019 | Chemist | $80,762 |
| 2018 | Supervisor, Quality Assurance | $80,000 |
| 2017 | Chemist II | $69,650 |
| 2017 | Sr. Validation & Project Engineer | $85,000 |
| 2017 | Senior Systems Analyst, SAP Applications | $117,368 |
| 2016 | Manager, IT Business Analysis | $108,971 |
| 2016 | Chemist III | $76,116 |
| 2016 | Chemist II | $56,500 |
| 2016 | Chemist II | $75,100 |
| 2016 | Chemist II | $69,650 |
| 2016 | Manager Analytical Filing | $87,989 |
| 2016 | Manager Analytical Filing | $87,989 |
Common questions about Jubilant Cadista Pharmaceuticals's H-1B filings
- How much does Jubilant Cadista Pharmaceuticals pay H-1B workers?
- Jubilant Cadista Pharmaceuticals's median certified H-1B base salary is $88k (FY2025), from 1 filings. See the full salary distribution and percentiles above.
- How many H-1B workers does Jubilant Cadista Pharmaceuticals sponsor?
- Jubilant Cadista Pharmaceuticals has 23 certified H-1B Labor Condition Applications on record (FY2016–FY2025).
- What jobs does Jubilant Cadista Pharmaceuticals sponsor for H-1B?
- Jubilant Cadista Pharmaceuticals's most-sponsored H-1B roles include Chemist II, Chemist, Manager Analytical Filing, Manager, Systems SAP Applications.
- Where does Jubilant Cadista Pharmaceuticals hire H-1B workers?
- Jubilant Cadista Pharmaceuticals's top H-1B worksite states are MD, PA.
- Does a certified LCA mean an H-1B visa was approved?
- No. A Labor Condition Application (LCA) is the Department of Labor attestation an employer must have certified before filing an H-1B petition with USCIS. It records the job, worksite and offered wage, but not whether the petition was filed, selected in the lottery, or approved. Filing counts measure intent to sponsor, not headcount.
- What salary do these figures show?
- The base annual wage offered on the certified LCA, converted to a yearly amount. Bonus, equity, overtime and benefits are not included, so total compensation is typically higher. Figures are medians and percentiles over certified filings; wages above $5,000,000 a year are excluded as data-entry errors.
- What do prevailing-wage levels I–IV mean?
- The Department of Labor assigns each LCA an OES wage level from I (entry) to IV (fully competent) for the occupation and area. Under the FY2027 wage-weighted H-1B lottery rule, a higher level earns more selection entries, so an employer's level mix is a proxy for how senior its sponsored roles are.
Keep exploring
Calculate your H-1B lottery odds →orCheck out the insights →
Source: U.S. Department of Labor, Office of Foreign Labor Certification — certified LCA disclosure data through June 2026 (FY2016–FY2025). An LCA is not an approved visa; pay figures are base salary and exclude bonus and equity. Methodology →